Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy

10.1038/s41413-018-0017-8

Saved in:

Bibliographic Details
Main Authors:	Madan, B, McDonald, M.J, Foxa, G.E, Diegel, C.R, Williams, B.O, Virshup, D.M
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Published:	Springer Nature 2020
Subjects:	alendronic acid osteocalcin osteoprotegerin sclerostin Wnt protein adipocyte animal experiment animal model animal tissue Article bone density bone marrow bone mass bone structure controlled study cortical thickness (bone) male micro-computed tomography morphometry mouse nonhuman osteoblast osteoclast osteolysis porcupine Wnt signaling
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/183825
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-183825
record_format	dspace
spelling	sg-nus-scholar.10635-1838252020-12-04T10:00:57Z Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy Madan, B McDonald, M.J Foxa, G.E Diegel, C.R Williams, B.O Virshup, D.M DUKE-NUS MEDICAL SCHOOL alendronic acid osteocalcin osteoprotegerin sclerostin Wnt protein adipocyte animal experiment animal model animal tissue Article bone density bone marrow bone mass bone structure controlled study cortical thickness (bone) male micro-computed tomography morphometry mouse nonhuman osteoblast osteoclast osteolysis porcupine Wnt signaling 10.1038/s41413-018-0017-8 Bone Research 6 1 17 2020-11-23T08:45:23Z 2020-11-23T08:45:23Z 2018 Article Madan, B, McDonald, M.J, Foxa, G.E, Diegel, C.R, Williams, B.O, Virshup, D.M (2018). Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy. Bone Research 6 (1) : 17. ScholarBank@NUS Repository. https://doi.org/10.1038/s41413-018-0017-8 2095-4700 https://scholarbank.nus.edu.sg/handle/10635/183825 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Springer Nature Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	alendronic acid osteocalcin osteoprotegerin sclerostin Wnt protein adipocyte animal experiment animal model animal tissue Article bone density bone marrow bone mass bone structure controlled study cortical thickness (bone) male micro-computed tomography morphometry mouse nonhuman osteoblast osteoclast osteolysis porcupine Wnt signaling
spellingShingle	alendronic acid osteocalcin osteoprotegerin sclerostin Wnt protein adipocyte animal experiment animal model animal tissue Article bone density bone marrow bone mass bone structure controlled study cortical thickness (bone) male micro-computed tomography morphometry mouse nonhuman osteoblast osteoclast osteolysis porcupine Wnt signaling Madan, B McDonald, M.J Foxa, G.E Diegel, C.R Williams, B.O Virshup, D.M Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy
description	10.1038/s41413-018-0017-8
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Madan, B McDonald, M.J Foxa, G.E Diegel, C.R Williams, B.O Virshup, D.M
format	Article
author	Madan, B McDonald, M.J Foxa, G.E Diegel, C.R Williams, B.O Virshup, D.M
author_sort	Madan, B
title	Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy
title_short	Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy
title_full	Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy
title_fullStr	Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy
title_full_unstemmed	Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy
title_sort	bone loss from wnt inhibition mitigated by concurrent alendronate therapy
publisher	Springer Nature
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/183825
_version_	1686109302505340928

Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy

Similar Items